Perspective · 26 Nov 2022
Short communicationPublished 3 Sep 2020
Nutrigenomics Perspective to Diabetes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diabetes Mellitus, regarded as a silent killer, has been demonstrated to be a prime global health concern with a projected rise in prevalence from 171 million in 2010 to 366 million in 2030. Correspondingly, dietary management has shown to be a cornerstone modality in the attainment of good glycemic control in diabetes, and Nutrition/Diet remains a key player in diabetes prevention and management. In this light, of course, evidences from prospective observational studies, clinical trials and experimental findings have reported ameliorating ability of a number foods and nutrient on diabetes. However, a major concern is the genetic variability of individuals and their responses to these functional foods. Therefore, it has become necessary to understand how nutrients act at the molecular level which in turn involves a cascade of nutrient-related interactions at the gene, protein and metabolic levels. Overall, a Nutrigenomic approach provides; a snapshot showing genes that are switched on/off (the genetic potential) at any given moment, and the method to determine the influence of nutrients on gene/protein expression. Nutrigenomic has opened a new future to screen the genetic background, to monitor the transcriptome, proteome and metabolome and to ultimately develop dietary strategies which are targeted to supply the optimum nutrition and therapeutics for single individuals. Fundamental new approach to nutrition research and novel experimental techniques like DNA microarray technology and quantitative real time Polymerase Chain Reaction (PCR) have successfully evaluated the interactions between diet and genes measured as changes in genetic expression. Nutrigenomics improves an understanding of how nutrients modifies expression of adipokines particularly, are those related to diabetes; leptin, adiponectin, resistin, visfatin, interleukins, and tumor necrosis factor-α (TNF-α), resulting to insulin resistance, β-cell dysfunction and then diabetes. Therefore, the present research aims to explore this issue.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 1 Nov 2016
New Perspectives in the Diagnosis and Treatment of Diabetic Gastroparesis
Other · 22 Jul 2016
Choice of monotherapy in newly diagnosed Type 2 diabetic patients: clinical perspective of ADOPT
Other · 12 Jul 2016
The clinical landscape of painful diabetic neuropathy therapy: perspectives for clinicians from clinical practice guidelines
Research article · 2012
Stakeholders’ perspectives on quality indicators for diabetes care: a qualitative study
More from this journal
The newest in Journal of Medicine and Medical Sciences.
Article · 30 Jul 2026
Contributing Factors to Violence against Women in Guinea: An Analysis of Individual, Relational, and Community Determinants
Article · 21 Jul 2026
Epidemiological, Behavioral and Judicial Profile of Sexual Assault Perpetrators in Conakry (Guinea): A Five-Year Medico-Legal Study of 1,014 Cases
Article · 12 Mar 2025
Fertility and Pregnancy in Breast Cancer Survivors
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medicine and Medical Sciences
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Nwawuba Stanley Udogadi”

